All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a non-profit multi-stakeholder collaborative program that aims to unify, accelerate and build on existing efforts, to make precision medicine a reality for all patients who could benefit from it. Co-led by patients, FT3 is strongly focused on patient needs and experiences.

All patients deserve access to the right testing & treatment at the right time

From Testing to Targeted Treatment Program (FT3) is a collaborative program to make precision medicine a reality for all patients who could benefit from it.

Program highlights

Could genetic testing unlock treatments for Cancer of Unknown Primary?

World CUP Week: Researchers are screening hundreds of tumour genes in search of drug targets that could open the door to more personalised cancer care

Find out more

Program update – September 2021

Here is an update on latest developments in FT3 including ideas to get involved and engage your network.

Find out more

2020 From Testing to Targeted Treatment Annual Report

Moving from incubation to a shared operational program

Read the full report here

Follow

laura mckeaveney @LauraMckeaveney·

Help build the accessibility conditions for Personalised Medicine. Participate in the stakeholder interview program... http://ow.ly/zMdt30rXuZw. #PrecisionMedicine https://twitter.com/FT3Program/status/1450366758926393348

Twitter 1451112816342179840

From Testing to Targeted Treatments (FT3)@FT3Program·

We're carrying out an interview-based survey to capture knowledge & experience of #precisionmedicine. The aim ... is to better understand how to build the accessibility conditions for PM. Want to participate in this stakeholder interviews program? 👇 http://ow.ly/zMdt30rXuZw

Twitter 1450366758926393348

PMC @permedcoalition·

With attention to the pandemic's tragically uneven impact, multi-sector leaders will convene during PMC's ... #PersonalizedMedicine Conference from May 19-20 to discuss how to align care more closely with patients' biology, circumstances, and values. #PMConf https://bit.ly/2Z6Gevd

Twitter 1450155371167944709

About us

Our motivation

All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.

Our ambition

Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.

Find out more

The partnership

We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.

Find out more

Keep up to date with developments from the precision medicine ecosystem

We don’t spam. Just key info at the right time.

Founding members

Join the partnership